KPTI - Financial Reports List - Karyopharm Therapeutics Inc. - IntrinsicAlpha

Karyopharm Therapeutics Inc. KPTI

Healthcare - Biotechnology - NASDAQ - US

$ 5.4

9.09 %

$ 46.3 M

Market Cap

-0.39

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-9.50%	26.43%	17.26%
Annual Report	FY	10-K	2024-12-31	-0.55%	46.60%	7.79%
Quarterly Report	Q3	8-K	2024-09-30	7.70%	7.05%	15.92%
Quarterly Report	Q2	8-K	2024-06-30	13.86%	172.91%	4.91%
Quarterly Report	Q1	8-K	2024-03-31	-14.40%	-9.48%	-9.26%
Quarterly Report	Q4	8-K	2023-12-31	0.50%	-8.65%	-11.63%
Annual Report	FY	10-K	2023-12-31	-7.03%	13.43%	8.90%
Quarterly Report	Q3	8-K	2023-09-30	-0.38%	5.00%	-1.37%
Quarterly Report	Q2	8-K	2023-06-30	-5.29%	33.49%	31.08%
Quarterly Report	Q1	8-K	2023-03-31	-18.82%	17.57%	10.66%

1